Geistlich Expands vallos Allograft Portfolio

Geistlich vallos Allograft

Geistlich Pharma North America introduced a growing variety of vallos allograft configurations to increase treatment flexibility through its partnership with MTF Biologics.

This expanded Geistlich Select product line offers:

A full portfolio of 35 variations, includes, granules, fibers, demineralized, mineralized and blended allografts

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us